“Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3/3b Trials”, J of Skin, vol. 10, no. 3, p. s772, May 2026, doi: 10.25251/pkdcct35.